Preventing Vitamin B6-Related Neurotoxicity

Area of Science:

• Biochemistry
• Human Physiology
• Nutritional Science

Background:

• Vitamin B6 is vital for numerous physiological processes, with pyridoxal 5'-phosphate (PLP) being the active form.
• Adequate B6 status requires plasma PLP >30 nmol/L, a level often unmet by standard dietary intake in elderly or comorbid patients.
• Current recommendations may lead to inadequate B6 status (<20 nmol/L), necessitating optimized supplementation strategies.

Purpose of the Study:

• To review the role of Vitamin B6 in human health.
• To evaluate current supplementation practices and their efficacy.
• To provide guidance on safe and effective Vitamin B6 dosing, focusing on PLP-based supplements.

Main Methods:

• Literature review utilizing PubMed.
• Analysis of randomized control trials and meta-analyses related to Vitamin B6.
• Evaluation of biochemical markers for Vitamin B6 status.

Main Results:

• Pyridoxal 5'-phosphate (PLP) is the preferred active form of Vitamin B6.
• Weekly low-dose PLP supplementation (50-100 mg) effectively maintains serum PLP levels (30-60 nmol/L).
• Daily supraphysiologic doses of B6 may lead to neurotoxicity, whereas PLP-based supplements show minimal neurotoxicity.

Conclusions:

• Vitamin B6 status assessment is important for unexplained anemia and chronic Mg deficiency.
• Weekly administration of low-dose PLP supplements is preferred to prevent toxicity and maintain adequate levels.
• Further research is needed to establish long-term safety of high-dose B6 supplements.